For example, the estimated incidence of angiotensin-converting enzyme (ACE) inhibitor-induced angioedema is 0.1 to 1.0 % [4] and that of hereditary angioedema (HAE) ranges from 0.002 to 0.01 % [5]. This evidence concerns the gene ACE and hereditary angioedema.